famotidine has been researched along with Stevens-Johnson Syndrome in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheinfeld, N | 1 |
Wesson, K | 1 |
Perry, P | 1 |
Weinberg, J | 1 |
Brunner, M | 1 |
Vardarman, E | 1 |
Goldermann, R | 1 |
Goerz, G | 1 |
Niederau, D | 1 |
Merk, HF | 1 |
Scharffetter-Kochanek, K | 1 |
2 other studies available for famotidine and Stevens-Johnson Syndrome
Article | Year |
---|---|
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu | 2003 |
Toxic epidermal necrolysis (Lyell syndrome) following famotidine administration.
Topics: Adult; Famotidine; Histamine H2 Antagonists; Humans; Male; Stevens-Johnson Syndrome | 1995 |